Comparison

PTEN Antibody (N-term)

Item no. ABC-AM8597b-ev
Manufacturer Abcepta
Amount 50 ul
Category
Type Antibody Primary
Format Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, followed by dialysis against PBS.
Applications WB
Specific against other
Host Mouse
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Similar products PTEN, Phosphatidylinositol 3, TEP1, MMAC1, 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, Mutated in multiple advanced cancers 1, Phosphatase and tensin homolog, 3.1.3.48, 3.1.3.16, 3.1.3.67
Available
Primary Accession
P60484
Antigen Type
Synthesized Peptide
Application
WB
Bio Background
Tumor suppressor. Acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine- phosphorylated proteins. Also acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3, 4, 5-trisphosphate, phosphatidylinositol 3, 4-diphosphate, phosphatidylinositol 3- phosphate and inositol 1, 3, 4, 5-tetrakisphosphate with order of substrate preference in vitro PtdIns(3, 4, 5)P3 > PtdIns(3, 4)P2 > PtdIns3P > Ins(1, 3, 4, 5)P4. The lipid phosphatase activity is critical for its tumor suppressor function. Antagonizes the PI3K- AKT/PKB signaling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival. The unphosphorylated form cooperates with AIP1 to suppress AKT1 activation. Dephosphorylates tyrosine-phosphorylated focal adhesion kinase and inhibits cell migration and integrin-mediated cell spreading and focal adhesion formation. Plays a role as a key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. May be a negative regulator of insulin signaling and glucose metabolism in adipose tissue. The nuclear monoubiquitinated form possesses greater apoptotic potential, whereas the cytoplasmic nonubiquitinated form induces less tumor suppressive ability. In motile cells, suppresses the formation of lateral pseudopods and thereby promotes cell polarization and directed movement.
Bio References
Li D.M., et al.Cancer Res. 57:2124-2129(1997).
Steck P.A., et al.Nat. Genet. 15:356-363(1997).
Li J., et al.Science 275:1943-1947(1997).
Hamilton J.A., et al.Br. J. Cancer 82:1671-1676(2000).
Wang S., et al.Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
Clonality
monoclonal
Clone/Animal Names
1096CT4.3.3
Gene ID
5728
Gene Name
PTEN
Subtitle
Purified Mouse Monoclonal Antibody (Mab)
Reactivity
H, M, Rat
Legend image 1
All lanes : Anti-PTEN Antibody (N-term) at 1:500-1:2000 dilution
Lane 1: Hela whole cell lysate
Lane 2: C6 whole cell lysate
Lane 3: NIH/3T3 whole cell lysate

Lysates/proteins at 20 µg per lane.

Secondary
Goat Anti-mouse IgG, (H+L), Peroxidase conjugated at 1/10000 dilution.

Predicted band size : 47 kDa

Blocking/Dilution buffer: 5% NFDM/TBST.
Type image 1
WB
Dilution image 1
1:500-1:2000
Other Accession
P60483; O08586; Q9PUT6
Predicted
X
Isotype
IgG1, k
Calculated MW
47166
Antigen Source
HUMAN
Target/Specificity
This PTEN antibody is generated from a mouse immunized with a KLH conjugated synthetic peptide between 10-44 amino acids from the N-terminal region of human PTEN.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 ul
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close